- Home
- Publications
- Publication Search
- Publication Details
Title
Myeloproliferative neoplasms – a global view
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-29
DOI
10.1111/bjh.18213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Classification of myeloid neoplasms/acute leukemia: global perspectives and the International Consensus Classification (ICC) approach
- (2022) Daniel A. Arber et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Randomized, Phase 3, Trial of Interferon-α versus Hydroxyurea in Polycythemia Vera and Essential Thrombocythemia
- (2022) John Mascarenhas et al. BLOOD
- Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: The Mayo Clinic experience
- (2022) Naseema Gangat et al. HAEMATOLOGICA
- Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases
- (2021) Kristell Mahe et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Polycythemia vera: historical oversights, diagnostic details, and therapeutic views
- (2021) Ayalew Tefferi et al. LEUKEMIA
- JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
- (2021) Naseema Gangat et al. LEUKEMIA
- RBC distribution width predicts thrombosis risk in polycythemia vera
- (2021) Dan Liu et al. LEUKEMIA
- Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
- (2021) Dan Liu et al. Blood Cancer Journal
- High‐oxygen‐affinity hemoglobinopathy‐associated erythrocytosis: Clinical outcomes and impact of therapy in 41 cases
- (2021) Naseema Gangat et al. AMERICAN JOURNAL OF HEMATOLOGY
- Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
- (2020) Heinz Gisslinger et al. Lancet Haematology
- Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management
- (2020) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
- (2019) Nico Gagelmann et al. BLOOD
- Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
- (2019) Donal McLornan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis
- (2018) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
- (2018) Paola Guglielmelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
- (2018) Tiziano Barbui et al. LEUKEMIA
- A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline
- (2018) Mary Frances McMullin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
- (2017) A Tefferi et al. LEUKEMIA
- A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
- (2017) F Passamonti et al. LEUKEMIA
- Polycythemia Vera Management and Challenges in the Community Health Setting
- (2017) Aaron T. Gerds et al. ONCOLOGY
- Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group
- (2016) Giada Rotunno et al. AMERICAN JOURNAL OF HEMATOLOGY
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea
- (2016) Genevieve Douglas et al. LEUKEMIA & LYMPHOMA
- Acute myeloid leukaemia: challenges and real world data from India
- (2015) Chepsy Philip et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
- (2015) J-J Kiladjian et al. LEUKEMIA
- Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
- (2015) N M Kröger et al. LEUKEMIA
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obstructive sleep apnea syndrome and secondary polycythemia: analysis of the nationwide inpatient sample
- (2015) Ranjan Pathak et al. SLEEP MEDICINE
- Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea
- (2014) Alberto Alvarez-Larrán et al. ANNALS OF HEMATOLOGY
- Generic imatinib: the real-deal or just a deal?
- (2014) Vikram Mathews LEUKEMIA & LYMPHOMA
- JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug
- (2013) E. T. Kuriakose et al. HAEMATOLOGICA
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
- (2013) A Tefferi et al. LEUKEMIA
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
- (2009) F. Passamonti et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now